Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 1 , Pages 63-69 , January 2007

Perceived Control is a Concurrent Predictor of Activity Limitations in Patients With Chronic Idiopathic Axonal Polyneuropathy

  • Carin Schröder, PT, MSc

      Affiliations

    • Department of Neurology and Neurosurgery, Rudolf Magnus Institute of Neuroscience, Sections of Rehabilitation Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands
    • Department of Physiotherapy Research, Academy of Health Sciences Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationReprint requests to Carin Schröder, PT, MSc, Dept of Physiotherapy Research, Academy of Health Sciences Utrecht, Huispostnr F00810, Postbox 85500, 3508 GA Utrecht, The Netherlands.
    • ,
  • Marie Johnston, PhD

      Affiliations

    • School of Psychology, University of Aberdeen, Aberdeen, UK
    • ,
  • Laurien Teunissen, PhD

      Affiliations

    • Department of Neurology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands
    • Department of Neurology, University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • Nicolette Notermans, PhD

      Affiliations

    • Neuromuscular Disease, University Medical Centre Utrecht, Utrecht, The Netherlands
    • Department of Neurology, University Medical Centre Utrecht, Utrecht, The Netherlands
    • ,
  • Paul Helders, MSc, PhD

      Affiliations

    • Department of Paediatric Physiotherapy and Exercise Physiology, Wilhelmina’s Children’s Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
    • ,
  • Nico van Meeteren, PT, PhD

      Affiliations

    • Department of Neurology and Neurosurgery, Rudolf Magnus Institute of Neuroscience, Sections of Rehabilitation Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands
    • Department of Physiotherapy Research, Academy of Health Sciences Utrecht, Utrecht, The Netherlands

References 

  1. Teunissen LL, Eurelings M, Notermans NC, Hop JW, van Gijn J. Quality of life in patients with axonal polyneuropathy. J Neurol. 2000;247:195–199
  2. Notermans NC, Wokke JH, Franssen H, et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry. 1993;56:1066–1071
  3. Verghese J, Bieri PL, Gellido C, Schaumburg HH, Herskovitz S. Peripheral neuropathy in young-old and old-old patients. Muscle Nerve. 2001;24:1476–1481
  4. Wolfe GI, Baker NS, Amato AA, et al. Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol. 1999;56:540–547
  5. Notermans NC, Wokke JH, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FG. Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry. 1994;57:1525–1527
  6. Hughes RA, Umapathi T, Gray IA, et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain. 2004;127(Pt 8):1723–1730
  7. Kissel JT. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Semin Neurol. 2003;23:169–180
  8. Hughes RA. Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy. Rev Neurol (Paris). 2002;158:S32–S36
  9. Merkies IS, Schmitz PI, Van Der Meche FG, Samijn JP, Van Doorn PA. Connecting impairment, disability, and handicap in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry. 2003;74:99–104
  10. Molenaar DS, Vermeulen M, de Visser M, de Haan R. Impact of neurologic signs and symptoms on functional status in peripheral neuropathies. Neurology. 1999;52:151–156
  11. World Health Organization. International classification of functioning disability and health. Geneva: WHO; 2001;
  12. Johnston M. Models of disability. Psychologist. 1996;9:205–210
  13. Carson AJ, Ringbauer B, MacKenzie L, Warlow C, Sharpe M. Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department. J Neurol Neurosurg Psychiatry. 2000;68:202–206
  14. Johnston M, Morrison V, MacWalter R, Partridge C. Perceived control, coping and recovery from disability following stroke. Psychol Health. 1999;14:181–192
  15. Johnston M, Pollard B, Morrison V, MacWalter R. Functional limitations and survival following stroke: psychological and clinical predictors of 3-year outcome. Int J Behav Med. 2004;11:187–196
  16. Arnstein P. The mediation of disability by self efficacy in different samples of chronic pain patients. Disabil Rehabil. 2000;22:794–801
  17. Fortinsky RH, Bohannon RW, Litt MD, et al. Rehabilitation therapy self-efficacy and functional recovery after hip fracture. Int J Rehabil Res. 2002;25:241–246
  18. Vrancken AF, van Schaik IN, Hughes RA, Notermans NC. Drug therapy for chronic idiopathic axonal polyneuropathy. Cochrane Database Syst Rev. 2004;(2):CD003456.
  19. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–607
  20. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of Functional Walk Tests used in the cardiorespiratory domain. Chest. 2001;119:256–270
  21. Taylor S, Frost H, Taylor A, Barker K. Reliability and responsiveness of the shuttle walking test in patients with chronic low back pain. Physiother Res Int. 2001;6:170–178
  22. Ware JE, Sherbourne CD The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  23. van der Zee KI, Sanderman R, Heyink J. Het meten van de algemene gezondheidstoestand met de RAND-36 een handleiding. Groningen: Noordelijk centrum voor gezondheid vraagstukken; 1985;
  24. Pollard B, Johnston M, Dieppe P. What do osteoarthritis health outcome instruments measure? (Impairment, activity limitation or participation restrictions?). J Rheumatol. 2006;33:757–763
  25. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther. 1996;76:248–259
  26. Notermans NC, Lokhorst HM, Franssen H, et al. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. Neurology. 1996;47:1227–1233
  27. van der Kloot WA, Oostendorp RA, van der Meij J, van den Heuvel J. [The Dutch version of the McGill pain questionnaire: a reliable pain questionnaire] [Dutch]. Ned Tijdschr Geneeskd. 1995;139:669–673
  28. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370
  29. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27:363–370
  30. Johnston M, Pollard B, Hennessey P. Construct validation of the Hospital Anxiety and Depression Scale with clinical populations. J Psychosom Res. 2000;48:579–584
  31. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Processes. 1991;50:179–211
  32. Conner M, Sparks P. The theory of planned behaviour and health behaviours. In:  Conner M,  Norman P editor. Predicting health behaviour. Buckingham: Open University Pr; 1996;p. 121–162
  33. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B. The MACTAR Patient Preference Disability Questionnaire—an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol. 1987;14:446–451
  34. van Genderen FR, van Meeteren NL, van der Bom JG, et al. Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List. Haemophilia. 2004;10:565–571
  35. Tabachnik BG, Fiddel LS. Using multivariate statistics. Harper Collins College Publishers. 3rd ed.. 1996;
  36. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173–1182
  37. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959–1964
  38. Bonetti D, Johnston M, Roderiguez-Marin J, et al. Dimensions of perceived control: a factor analysis of three measures and an examination of their relation to activity level and mood in a student and cross-cultural patient sample. Psychol Health. 2001;16:655–674
  39. Johnston M, Gilbert P, Partridge C, Collins J. Changing perceived control in patients with physical disabilities: an intervention study with patients receiving rehabilitation. Br J Clin Psychol. 1992;31(Pt 1):89–94
  40. Ryan S, Hassell A, Dawes P, Kendall S. Control perceptions in patients with rheumatoid arthritis: the impact of the medical consultation. Rheumatology (Oxford). 2003;42:135–140
  41. Fisher K, Johnston M. Experimental manipulation of perceived control and its effect on disability. Psychol Health. 1996;11:657–669

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(06)01432-8

doi: 10.1016/j.apmr.2006.10.024

Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 1 , Pages 63-69 , January 2007

Article Tools